<html>
<head>PUBMED IDs for LAPSER1</head>
<body bgcolor='#C5F0F2'><h1>LAPSER1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16012743/'>In silico characterization of LZTS3, a potential tumor suppressor.</a> July 14  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17351128/'>LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin.</a> March 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490357/'>LAPSER1/LZTS2: a pluripotent tumor suppressor linked to the inhibition of katanin-mediated microtubule severing.</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490349/'>Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction.</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18490283/'>Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: are all etiologies identical?</a> May 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19703901/'>Synaptic cross-talk between N-methyl-D-aspartate receptors and LAPSER1-beta-catenin at excitatory synapses.</a> December 16  2009<br></body></html>
